Workshop Report on ‘Rare Cancers : The Added Value of Closer Cooperation’

15-08-2011

This document summarises the presentations and discussions at the Workshop on Rare Cancers: The added value of cooperation held at the European Parliament in Brussels on Tuesday 12 July 2011. The aim of the workshop was to review this issue with representatives of EU institutions, patient associations as well as scientific experts, in the context of the expected update of the Clinical Trials Directive. The meeting also aimed at increasing awareness about the importance of Rare Cancers. The workshop was co-chaired by Glenis WILLMOTT and Alojz PETERLE, MEPs on behalf of the Working Group Health of the European Parliament's Committee on Environment, Public Health and Food Safety (ENVI).

This document summarises the presentations and discussions at the Workshop on Rare Cancers: The added value of cooperation held at the European Parliament in Brussels on Tuesday 12 July 2011. The aim of the workshop was to review this issue with representatives of EU institutions, patient associations as well as scientific experts, in the context of the expected update of the Clinical Trials Directive. The meeting also aimed at increasing awareness about the importance of Rare Cancers. The workshop was co-chaired by Glenis WILLMOTT and Alojz PETERLE, MEPs on behalf of the Working Group Health of the European Parliament's Committee on Environment, Public Health and Food Safety (ENVI).

Autorzy zewnętrzni

Kerina Tull, Vanessa Leigh and Tony Zamparutti (Milieu Ltd., Brussels, Belgium)